← Open Payments lookup

MEGAN CHAISSON: Open Payments

NPI 1649850124 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,666 in 59 payments from 14 companies in 2025. Trend: 2023 $519 · 2024 $1,312 · 2025 $1,666

Food & beverage: $1,666
CompanyPaymentsAmount
ABBVIE INC.12$225
Neurocrine BioSciences, Inc.5$211
Janssen Pharmaceuticals, Inc3$177
Otsuka America Pharmaceutical, Inc.4$161
E.R. Squibb & Sons, L.L.C.11$149
Alkermes, Inc.4$130
Merck Sharp & Dohme LLC6$129
Teva Pharmaceuticals USA, Inc.2$124
Axsome Therapeutics, Inc.2$117
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$113

Products named: VRAYLAR, INGREZZA, SPRAVATO, COBENFY, REXULTI, ARISTADA, PIFELTRO, Auvelity.

Industry payments across LA — which companies pay providers there.